Theragenics launches "Dutch auction" tender offer; Israeli med device stocks plunge after Spain's bailout;

 @FierceMedDev: FTC: JNJ will have to sell its wrist fractures unit in order to complete its Synthes buy. More | Follow @FierceMedDev

> Endosense gained a CE mark for its new ablation catheter to treat cardiac arrhythmia. Biotronik is distributing the product. Release

> Senator Dan Coats (R-IN) is calling for a Senate vote on the repeal of the 2.3% medical device tax passed in the House last week. Senate Democrats have said they won't bring the issue up for debate, and the White House has threatened a veto even if it passed. More

> GenMark Diagnostics ($GNMK) has increased its revenue projection for 2012 from $10 million to more than $15 million, citing an increased customer base for its molecular diagnostic testing systems. News

> Medical device industry leaders are gathering in Galway, Ireland on June 15 for a symposium intended to boost medical device business in the country. Story

> Theragenics ($TGX), a medical device company that makes surgical and prostate cancer treatment products, will launch a "Dutch auction" tender offer in order to purchase up to $10 million of its common stock. Release

Biotech News

 @FierceBiotech: Stanford spinoff Syapse debuts cloud-based R&D software. News | Follow @FierceBiotech

 @JohnCFierce: Ain't it cool: Novartis/UCSF team develop computer program to spot potential adverse side effects in experimental drugs. More | Follow @JohnCFierce

> Sanofi presents parallel apps for blockbuster MS hopeful Lemtrada. Story

> Third Rock takes lead on $33M C round for antibody upstart Igenica. Article

> Buzz: GlaxoSmithKline interested in BioMarin buyout? More

> GSK continues deal spree with $302M pact for Basilea eczema drug. News

Pharma News

 @FiercePharma: Analysts see Glaxo boosting its bid for Human Genome, but only by $1 or $2 per share--BloombergStory | Follow @FiercePharma

> ADA cancer-risk data clears Sanofi's Lantus. News

> Forest Labs slashes forecast on wilting Lexapro sales. Article

> NICE does an about-face, nixing cancer nod on Xgeva. Story

Biotech Research News

> Anti-rejection drug for bone marrow transplants to hit human trials by 2016. Story

> 2 HIV drugs prevent breast cancer metastasis in preclinical trials. Article

> New drug shows reduces post-stroke brain damage risk in mice. More

> Enzyme revealed to be bacteria-killing maestro after all. Item

Pharma Manufacturing News

> Siemens faces more issues with U.S. regulators.  Story

> Fresenius' Kabi unit prospering on mistakes of competitors. Article

> Lilly expands manufacturing in China with Novast deal. News

> Out of the box FDA says Perjeta faces shortage challenges. More

And Finally... A number of Israeli stocks are tumbling in the U.S. because of worries that Spain's bailout won't resolve the ongoing European debt crisis. Europe, of course, is Israel's biggest trading partner, as Bloomberg reports. Story

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.